Phaseline

Companies › ProofPilot

ProofPilot: clinical trials, targets and expected readouts

1 active drug program in 1 registered trial: 1 Phase 4; Psychiatry.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
Fisher Wallace Neurostimulation Device (Cranial Electrotherapy Stimulator Device
Cranial electrotherapy stimulation
–Phase 4Insomnia–

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT04627480Fisher Wallace Neurostimulation Device (Cranial Electrotherapy Stimulator DevicePhase 4InsomniaPsychiatryJan 2021

Targets

No annotated target.

Companies with the same targets

–

Companies built like this

Samuel Fortin Oui Therapeutics Taysha Gene Therapies Curemark Emalex Biosciences

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.